Skip to main content
Fig. 1 | Journal of Experimental & Clinical Cancer Research

Fig. 1

From: Blood-based biomarkers in patients with non-small cell lung cancer treated with immune checkpoint blockade

Fig. 1

Clinical application of blood-based biomarkers in NSCLC. This figure showcases the potential clinical application of blood-based biomarkers in NSCLC patients treated with immunotherapy. Blood-based biomarkers may have a potential role in understanding the biology of a given agent in humans, patient selection, monitoring of treatment, and prediction of patient outcomes in response to therapy. (Created with BioRender.com)

Back to article page

Journal of Experimental & Clinical Cancer Research

ISSN: 1756-9966

Contact us